Report of Foreign Issuer (6-k)

 

---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2014

Commission File Number: 001-34975

IMRIS INC.
(Translation of registrant's name into English)

100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

☐ Form 20-F

☒ Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

---

 

 

DOCUMENTS FILED AS PART OF THIS FORM 6-K

 

See the Exhibit Index hereto.

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

	IMRIS Inc.
	(Registrant)
Date: November 17, 2014	By:	/s/ Jay D. Miller
		_____________________________________
	Name:	Jay D. Miller
	Title:	President, Chief Executive Officer and Director

 

---

 

EXHIBIT INDEX

99.1	News Release dated November 17, 2014 - IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

 

 

---

 

Exhibit 99.1

 

IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

MINNEAPOLIS, Nov. 17, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum at the Westin Grand Central, New York at 8:40 a.m. Eastern Time on Thursday, November 20, 2014. 

The slides of Mr. Miller's presentation will be available at www.imris.com, and can be found under Investors, Events & Presentations.  The presentation will be webcast live at http://wsw.com/webcast/canaccord16/imrs and can also be accessed through the investor relations page at http://www.imris.com/investors/events-and-presentations.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre – a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by 61 leading medical institutions around the world. For more information, visit www.imris.com.

 

SOURCE IMRIS Inc.

 

%CIK: 0001489161

 

For further information: Jeffery Bartels, Director - Finance, IMRIS Inc., Tel: [phone], Email: [e-mail]

CO: IMRIS Inc.

CNW 16:53e 17-NOV-14